Skip to main content
. Author manuscript; available in PMC: 2023 Mar 2.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1769–1779. doi: 10.1158/1055-9965.EPI-22-0123

Table 3.

Genes associated with risk of TGCT based on analysis of all SNPs in each gene

GENE N SNPs* perm-p# q-value§
MTHFR 13 3×10−5 8.4×10−4
MECP2 4 1.4×10−4 2×10−3
ZBTB4 7 3.2×10−3 0.03
AHCY 4 0.05 0.35
MBD3L1 5 0.07 0.35
SHMT1 8 0.1 0.35
MAT1A 14 0.1 0.35
DNMT3L 16 0.1 0.35
DNMT1 8 0.17 0.42
MAT2B 9 0.18 0.42
DNMT3B 8 0.19 0.42
ZBTB38 4 0.19 0.42
UHRF1 13 0.20 0.42
MTRR 25 0.25 0.46
TET2 9 0.26 0.46
MBD2 10 0.27 0.46
CBS 17 0.30 0.50
TET3 11 0.44 0.69
MBD3 4 0.53 0.75
BHMT 13 0.53 0.75
DNMT3A 18 0.56 0.75
MAT2A 4 0.59 0.75
TET1 7 0.65 0.76
MBD2 7 0.65 0.76
CTCF 3 0.76 0.85
MTR 8 0.81 0.87
MBD4 3 0.94 0.96
GADD45b 8 0.96 0.96
*

Number of SNPs tested within a gene

#

Gene level p-value computed by MAGMA after 100,000 permutations

§

Gene level q-value calculated on permutation p-value